Metabolic syndrome and unfavorable outcomes on body composition and in visceral adiposities indexes among early breast cancer women post-chemotherapy
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 44, 306-315
Abstract
No abstract availableKeywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/07963\u20130)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/09877\u20139)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/09877?)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/07963?)
This publication has 72 references indexed in Scilit:
- Comorbidity and survival of Danish breast cancer patients from 2000–2011: a population-based cohort studyClinical Epidemiology, 2013
- The impact of comorbidity on cancer survival: a reviewClinical Epidemiology, 2013
- Evaluating the effect of measurement error when using one or two 24 h dietary recalls to assess eating out: a study in the context of the HECTOR projectBritish Journal of Nutrition, 2013
- Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trialDiabetologia, 2011
- Metabolic syndrome and the risk of breast cancer in postmenopausal womenAnnals of Oncology, 2011
- Visceral Adiposity IndexDiabetes Care, 2010
- Care of the Cancer Survivor: Metabolic Syndrome after Hormone-Modifying TherapyThe American Journal of Medicine, 2010
- A comprehensive definition for metabolic syndromeDisease Models & Mechanisms, 2009
- Bioelectrical impedance phase angle as a prognostic indicator in breast cancerBMC Cancer, 2008
- The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27Journal of Clinical Oncology, 2003